Scarica l'app Stockscreener
13.07
2.02%
-0.27
Precedente Chiudi:
$13.34
Aprire:
$12.93
Volume 24 ore:
383.04K
Relative Volume:
0.21
Capitalizzazione di mercato:
$542.66M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-7.9695
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
+8.29%
1M Prestazione:
-7.63%
6M Prestazione:
-60.63%
1 anno Prestazione:
-52.64%
Intervallo 1D:
$12.62
$13.42
Intervallo di 1 settimana:
$12.24
$14.73
Portata 52W:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
500 BOYLSTON STREET, BOSTON
Compare VOR vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
13.07 | 553.87M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | Citigroup | Buy |
| 2025-12-17 | Iniziato | TD Cowen | Buy |
| 2025-12-09 | Iniziato | JP Morgan | Overweight |
| 2025-11-25 | Ripresa | Wedbush | Neutral |
| 2025-10-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Vor Biopharma (NASDAQ:VOR) Stock Price Down 4%What's Next? - MarketBeat
Vor Biopharma Shares Skyrocket on Global Licensing Deal for Autoimmune Therapy - MSN
Exit Recap: Can Vor Biopharma Inc. keep up with sector leadersJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
VOR Stock Unaffected by Selling Stockholders' Actions - GuruFocus
Is Vor Biopharma Inc. gaining market shareDollar Strength & Real-Time Stock Price Movement Reports - mfd.ru
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Aug EndMonth: What is the PEG ratio of Vor Biopharma IncGap Down & High Conviction Trade Alerts - baoquankhu1.vn
VOR: TD Cowen Initiates Coverage with a 'Buy' Rating | VOR Stock News - GuruFocus
VOR: Telitacicept drives a global autoimmune strategy, backed by strong data, funding, and expert leadership - TradingView — Track All Markets
Quarterly Risk: How Vor Biopharma Inc stock valuations compare to rivals2025 Retail Activity & Weekly Top Performers Watchlists - Bộ Nội Vụ
Citigroup Initiates Coverage of Vor Biopharma (VOR) with Buy Recommendation - Nasdaq
Vor Biopharma (VOR) Receives New 'Buy' Rating From Citigroup | V - GuruFocus
Citigroup Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat
Citi Starts Vor Biopharma, Inc. (VOR) at Buy - StreetInsider
How Vor Biopharma Inc. stock responds to policy changes2025 EndofYear Setup & Growth Focused Investment Plans - ulpravda.ru
Will Vor Biopharma Inc. stock return to pre crisis levelsMarket Sentiment Report & Community Consensus Picks - ulpravda.ru
How Vor Biopharma Inc. stock valuations compare to rivals2025 Year in Review & High Accuracy Swing Entry Alerts - Улправда
Why Vor Biopharma Inc. stock remains a top recommendationTrade Volume Report & Stock Timing and Entry Methods - ulpravda.ru
Guidance Update: How Vor Biopharma Inc. stock responds to policy changes2025 Geopolitical Influence & AI Forecasted Stock Moves - Улправда
Why Vor Biopharma Inc. stock is a must watch in 2025Market Rally & Stepwise Entry and Exit Trade Signals - ulpravda.ru
How Vor Biopharma Inc. stock benefits from global expansionMonthly Performance Summary & Start Small. End Wealthy. - bollywoodhelpline.com
Vor Biopharma raises $42 million for cell therapy in leukemia | Biotechnology | The Pharmaletter - The Pharma Letter
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
What drives Vor Biopharma Inc stock priceInstitutional Buying Trends & Low Entry Cost Trading - earlytimes.in
Ariose Capital Management Ltd Invests $5.37 Million in Vor Biopharma Inc. $VOR - MarketBeat
Vor Biopharma Inc Stock Analysis and ForecastSell Signals and Alerts & Free High Yield Growth Strategies - earlytimes.in
Aug Macro: Will Vor Biopharma Inc stock outperform international peersFed Meeting & Verified Momentum Stock Watchlist - moha.gov.vn
Vor Biopharma CDO Departs, Transition Support Planned - TipRanks
Vor Biopharma Target of Unusually High Options Trading (NASDAQ:VOR) - MarketBeat
Portfolio Update: How Vor Biopharma Inc. stock benefits from global expansionTrade Risk Report & Fast Entry and Exit Trade Plans - moha.gov.vn
Vor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors - ts2.tech
Gap Down: Is Vor Biopharma Inc stock positioned well for digital economyJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - moha.gov.vn
Vor Biopharma (VOR) Stock Analysis Report | Financials & Insights - Benzinga
Vor Biopharma Inc. (NASDAQ:VOR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Moving Averages: How strong is Celsius Holdings Inc stock balance sheet2025 Short Interest & Community Verified Swing Trade Signals - moha.gov.vn
Vor Biopharma Stock (+7.4%): New Board Signals Institutional Backing - Trefis
Vor Biopharma Inc. (NASDAQ:VOR) Sees Large Growth in Short Interest - MarketBeat
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors - The Globe and Mail
Vor Biopharma adds two investment partners to board of directors By Investing.com - Investing.com Nigeria
Vor Biopharma Inc Announces Board Appointments - marketscreener.com
Vor Biopharma Inc.(NasdaqGS: VOR) added to NASDAQ Biotechnology Index - marketscreener.com
VOR: JP Morgan Lowers Price Target While Maintaining Overweight Rating | VOR Stock News - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Vor Biopharma (NASDAQ:VOR) Stock Price - MarketBeat
Why Vor Biopharma Inc. stock appeals to dividend seekersJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - ulpravda.ru
Vor Biopharma Signs Multiple Financing Agreements - TradingView — Track All Markets
Vor Biopharma (VOR) secures $150M private placement and adds two directors - Stock Titan
Technical Analysis: Will Vor Biopharma Inc. stock reach all time highs in 2025Earnings Performance Report & Accurate Technical Buy Alerts - Улправда
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):